Oncology Social Workers are integral members of the cancer care team, providing emotional, practical, and social support to patients and their families throughout every stage of the cancer journey. They help individuals navigate the overwhelming challenges that often accompany a cancer diagnosis, including emotional distress, financial hardship, complex medical systems, and changes in family dynamics. By offering counseling and support, oncology social workers empower patients to cope with fear, anxiety, depression, and uncertainty, helping them maintain a sense of control and resilience during a difficult time.
Oncology social workers assist patients in accessing vital resources, such as transportation, housing support, financial assistance, and insurance navigation. They help remove barriers that might interfere with treatment, ensuring patients receive continuous and comprehensive care. Oncology social workers also advocate for patients’ rights and preferences, facilitating communication between the patient, their family, and the healthcare team to ensure care decisions reflect the patient’s values. They support caregivers and loved ones as well, offering guidance in managing caregiver stress, planning for end-of-life care, or coping with grief and loss. Many oncology social workers also lead support groups and provide education to help patients connect with others facing similar challenges. Through their compassionate, patient-centered approach, oncology social workers contribute to better emotional outcomes, improved access to care, and a higher quality of life for those affected by cancer.
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China